Spots Global Cancer Trial Database for Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2
Official Title: A Multi-center Phase Ib Trial Evaluating the Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2
Study ID: NCT05321147
Conditions
Interventions
Study Description
Brief Summary: This is a multi-center phase Ib study, which evaluates the safety and efficacy of lacutamab monotherapy in patients with relapsed/refractory peripheral T-cell lymphoma that express KIR3DL2.
Detailed Description: This is an open-label, single-arm multicenter study. Eligible patients will be enrolled and will receive fixed dose of 750mg Lacutamab as a 1-hour IV infusion.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Alabama at Birmingham- O'Neal Comprehensive Cancer Center, Birmingham, Alabama, United States
University of California at Irvine - Chao Family Comprehensive Cancer Center, Orange, California, United States
Goshen Health- Goshen Hospital, Goshen, Indiana, United States
Indiana University School of Medicine, Indianapolis, Indiana, United States
University of Iowa, Iowa City, Iowa, United States
University of Maryland, Baltimore, Maryland, United States
Memorial Sloan Kettering Cancer Center- David H. Koch Center for Cancer Care, New York, New York, United States
Allegheny Health, Pittsburgh, Pennsylvania, United States
Medical University of South Carolina - Health Hollings Cancer Center, Charleston, South Carolina, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Inje University Busan Paik Hospital, Busan, , Korea, Republic of
Chungnam National University Hospital, Daejeon, , Korea, Republic of
Seoul National University Bundang Hospital, Gyeonggi-do, , Korea, Republic of
Gachon University Gil Medical Center, Incheon, , Korea, Republic of
The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
Korea University Anam Hospital, Seoul, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Severance Hospital Yonsei University Health System, Seoul, , Korea, Republic of
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
